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a b s t r a c t
To ensure optimal environments for their replication and spread, viruses have evolved to alter many host
cell pathways. In the last decade, metabolomic studies have shown that eukaryotic viruses induce large-
scale alterations in host cellular metabolism. Most viruses examined to date induce aerobic glycolysis
also known as the Warburg effect. Many viruses tested also induce fatty acid synthesis as well as
glutaminolysis. These modiﬁcations of carbon source utilization by infected cells can increase available
energy for virus replication and virion production, provide speciﬁc cellular substrates for virus particles
and create viral replication niches while increasing infected cell survival. Each virus species also likely
requires unique metabolic changes for successful spread and recent research has identiﬁed additional
virus-speciﬁc metabolic changes induced by many virus species. A better understanding of the metabolic
alterations required for the replication of each virus may lead to novel therapeutic approaches through
targeted inhibition of speciﬁc cellular metabolic pathways.
& 2015 Elsevier Inc. All rights reserved.
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Introduction
Viruses are non-living entities and as such do not inherently have
their own metabolism. However, within the last decade, it has
become clear that viruses dramatically modify cellular metabolism
upon entry into a cell. Viruses have likely evolved to induce
metabolic pathways for multiple ends. Virus-induced metabolism
may provide increased pools of free nucleotides necessary for rapid
viral genome replication as well as increased amino acid production
for rapid virion assembly. For enveloped viruses, increased lipid
material may be needed to provide additional membrane material
for envelopment of the viral particles. Alteration of cellular metabo-
lism by viruses could also be necessary to provide speciﬁc substrates
that are uniquely required at high levels for virion production, for
example increased glycoproteins for viral envelopes. In addition to
providing direct substrates for virion production, adjustments to
metabolic pathways may be required to provide ATP in a rapid
fashion for the high energy costs of genome replication and packa-
ging. Altered cellular metabolism may aid in the survival of infected
cells during the stress of viral infection. Identiﬁcation of how viruses
alter cellular metabolism and where in the virus life cycle these
metabolic changes are necessary will provide a deeper understand-
ing of virus replication needs and potentially provide cellular targets
for inhibition of viruses.
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While there were clear indications from studies in the 1950s
and 1960s that virus infection require speciﬁc metabolic pathways
for replication, identiﬁcation of virus induced metabolic pathways
has been facilitated by recent technological advances. Advanced
mass spectrometry techniques can concurrently measure the
levels of many metabolites and measure carbon ﬂux through the
metabolic system. The term metabolomics was coined to describe
experiments where large numbers of cellular metabolite levels are
measured concurrently. These studies yield a broader comparison
of mock- and virus-infected cell metabolite levels and can identify
large-scale changes induced by a virus. Additionally, technological
advances have led to the ability to measure carbon ﬂux by
following isotope labeled carbon that, while difﬁcult to perform,
have allowed a better understanding of the fate of extracellular
carbon sources.
In 2006, the ﬁrst eukaryotic virus-infected cell metabolomics
study led the resurgence of the virus-induced metabolism ﬁeld.
The study analyzed over 60 metabolites during human cytomega-
lovirus infection (HCMV) (Munger et al., 2006). The metabolomics
study was followed up with a carbon ﬂux analysis that provided a
clearer picture of the ﬂow of carbon from labeled glucose and
glutamine following CMV infection, further showing how carbon is
utilized in the infected cell (Munger et al., 2008). Since these ﬁrst
studies, a number of viruses have been shown to alter multiple
major metabolic pathways and have expanded the number of
metabolites measured (Birungi et al., 2010; Delgado et al., 2012;
Diamond et al., 2010; Fontaine et al., 2014; Fontaine et al., 2015;
Hollenbaugh et al., 2011; Lin et al., 2010; Ritter et al., 2010; Roe
et al., 2011; Vastag et al., 2011). A number of core cellular
metabolic pathways, including glycolysis, fatty acid synthesis and
glutaminolysis, are signiﬁcantly altered by multiple virus families
(Table 1). These core pathways are often similarly activated in
many cancer cells. Therefore, it is important that, when possible,
metabolomics studies are done in primary or minimally immorta-
lized cells. While information can still be gleaned from studies in
transformed cells, many pathways are masked by metabolic
switches that are triggered during oncogenesis and in some cases
cell lines are immortalized by oncogenic viruses or viral proteins
that could contribute to the metabolic proﬁle observed. The
importance of glycolysis, fatty acid synthesis and glutaminolysis
to viral infections is discussed below.
Glycolysis
Primary mammalian cells under standard growth conditions
predominantly utilize glucose for oxidative phosphorylation in the
mitochondria. Glucose is metabolized to pyruvate through multi-
ple steps. Pyruvate is then translocated to the mitochondria, where
it enters the TCA cycle and ultimately drives the electron transport
chain, in a process that requires oxygen. In anaerobic conditions,
glucose is primarily utilized for glycolysis where it is metabolized
to pyruvate and then is converted to lactate and pumped out of the
cell. In most cancer cells glucose is primarily utilized for the
production of lactic acid even in the presence of abundant oxygen,
a process often referred to as aerobic glycolysis or the Warburg
effect. While oxidative phosphorylation provides signiﬁcantly
more ATP per glucose, glycolysis is a much faster process providing
ATP rapidly. However, utilizing glycolysis as the main metabolic
pathway for glucose requires increased uptake of extracellular
glucose to match the increased metabolic rate. While cancer cells
utilize aerobic glycolysis, it is not clear if the switch is needed for
faster production of ATP or if the production of lactate and higher
levels of glycolytic intermediates are advantageous as a source of
biomass.
Early hints that glycolysis was required for viral replication
came from viral infection studies in the 1950s and 1960s. In 1956,
it was shown that the propagation of poliovirus in Hela cells was
blocked in minimal media but the addition of glucose recovered a
signiﬁcant portion of the viral titer (Eagle and Habel, 1956). This
ﬁnding was subsequently conﬁrmed in primary monkey kidney
cells where an increase in lactate in the media during the ﬁrst two
hours of infection was also shown (Baron and Levy, 1956; Levy and
Baron, 1957). In 1962, it was shown that HSV-1 passage in Hela
cells was dependent on the presence of glucose but not glutamine
in the media (Lewis and Scott, 1962). In the absence of glucose,
HSV-1 penetrated cells equally but did not produce infectious
progeny. It was subsequently shown that HSV-1 virion production
did not decrease signiﬁcantly in the presence of 2-deoxyglucose
(2-DG), a competitive inhibitor of glucose for hexokinase-2, HK2
(Courtney et al., 1973). However, the production of infectious
particles was severely impaired in the presence of 2-DG, possibly
due to alterations in the viral glycoproteins. Similar studies with
pseudorabies, another alphaherpesvirus, found that viral nucleic
acid replication did not require glycolysis and viral proteins were
produced in the presence of 2-DG but there was a signiﬁcant
decrease in the production of infectious virus (Ludwig and Rott,
1975). These data show that virus production requires glycolysis
for a later step in replication, possibly late gene synthesis, virion
assembly or egress, and is not due to the simple explanation that
cell integrity is compromised by the lack of glucose. Through the
1980s and 1990s studies of glycolysis and metabolism in virus-
infected cells were mostly limited to transforming retroviruses
where the effect was clouded by the transformation of the cells by
the virus. However, there were studies showing that some viruses,
including HCMV and HSV, induced glucose uptake (Landini, 1984;
Saito and Price, 1984).
The ﬁrst eukaryotic virus-infected cell metabolomics study
found that glycolytic intermediates were induced following HCMV
infection (Munger et al., 2006). This study measured over 60
metabolites following HCMV infection of primary human foreskin
ﬁbroblasts (HFF) cells. A number of glycolytic intermediates were
signiﬁcantly increased following infection. Flux analysis demon-
strated an increased ﬂux of glucose carbon through glycolysis
Table 1
Virus Essential carbon source/
important metabolic pathway
Major publications
Poliovirus Glucose Eagle and Habel (1956)
Glutamine Darnell and Eagle (1958)
Fatty acid synthesis Nchoutmboube et al. (2013)
HCMV Fatty acid synthesis Munger et al. (2006)
Glucose and glycolysis Munger et al. (2008)
Glutamine and glutaminolysis Chambers et al. (2010)
Vastag et al. (2011)
DENV Fatty acid synthesis Heaton et al., 2010
Glycolysis Perera et al. (2012)
Fontaine et al. (2014)
HCV Fatty acid synthesis Kapadia and Chisari (2005)
Glycolysis Ripoli et al. (2010)
Diamond et al. (2010)
Ramiere et al. (2014)
VACV Glutaminolysis Fontaine et al. (2014)
Fatty Acid Synthesis Greseth and Traktman (2014)
HSV-1 Glucose and Glycolysis? Lewis and Scott (1962)
Courtney et al. (1973)
McArdle et al. (2011)
Vastag et al. (2011)
Ad5 Glycolysis Thai et al. (2014)
KSHV (latency) Glycolysis Delgado et al. (2012)
Fatty acid synthesis Bhatt et al. (2012)
Glutamine and glutaminolysis Delgado et al. (2012)
Yogev et al. (2014)
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ultimately leading to an increase in lactate production (Munger
et al., 2008). Subsequent studies examined the mechanism of
HCMV induction of glucose uptake and glycolysis. Viral protein
expression is required for HCMV induced glycolysis, as cyclohex-
amide blocks induction (McArdle et al., 2011). It appears that early
genes are necessary for HCMV induction of glyocolysis as phos-
phonoacetic acid, an inhibitor of viral replication that prevents the
expression of late viral genes, has no effect on HCMV induced
glycolysis. This study also analyzed a cellular pathway know to be
important for increased glycolysis in cancer cells, the calmodulin-
dependent protein kinase family. An inhibitor of CAMKK, but not
CaMKII, blocks HCMV induced glycolytic ﬂux (McArdle et al.,
2011). Additionally, the CAMKK inhibitor blocks viral replication
and late gene synthesis and the production of viral progeny. Taken
together, these data show that HCMV requires glycolysis for
replication of the viral genome. Interestingly, the CAMKK inhibitor
has little effect on HSV-1, an alphaherpesvirsus, while 2-DG
inhibits the two viruses equally (McArdle et al., 2011). Therefore,
the mechanism for the virus-induction of glycolysis is virus species
speciﬁc. HCMV also alters glucose transporter expression on
infected HFF cell membranes (Yu et al., 2011b). There are a number
of transporters, some of which are ubiquitous and some are
differentially expressed between cell types. HCMV downregulates
the ubiquitously expressed glucose transporter-1 (glut1) and
concurrently increases the expression of glut4, a more efﬁcient
glucose transporter that can accelerate glucose uptake (Yu et al.,
2011b). Therefore, HCMV induces a shift in glucose transporter
expression allowing increased glucose accumulation in infected
cells. An inhibitor of glut4 decreased glucose uptake in infected
HFF cells, as well as the production of infectious CMV. Though
much is known about how HCMV alters glycolysis, the viral genes
necessary for viral induction have not been elucidated and there
are likely more cellular pathways involved.
Adenovirus, a non-enveloped double stranded DNA virus also
induces glycolysis. Adenovirus5 infection of non-tumorigenic
breast epithelial cells leads to increased glucose consumption
and lactic acid production with a concurrent decrease in oxygen
consumption (Thai et al., 2014). Expression of the viral gene,
E4ORF1, is sufﬁcient to induce glycolysis but did not decr-
ease oxygen consumption, indicating these might be separable
functions in adenovirus infected cells. E4ORF1 induces and
co-imunoprecipitates with Myc and its interaction with Myc is
required for the induction of glycolysis. An adenovirus expressing
a mutant E4ORF1 that does not induce Myc also does not induce
glycolysis supporting the conclusion that activation of Myc is
involved in the viral induction of this glycolysis. Adenovirus
infection led to increased carbon ﬂux into nucleotides and when
radiolabeled glucose was added to infected cell media, adenovirus
DNA was labeled (Thai et al., 2014). Carbon ﬂux into nucleotides
and adenovirus DNA replication was blunted when cells were
infected with the adenovirus mutant where E4ORF1 could not
activate Myc. Therefore, it appears that adenovirus induces Myc to
activate glycolysis and nucleotide synthesis for adenovirus DNA
replication. Interestingly, knockdown of Myc with shRNA led to a
one-log decrease in virus titer in epithelial cells with low glycolytic
rates but not in cells with high glycolytic rates (Thai et al., 2014).
Therefore, activation of Myc and glycolysis is required for maximal
adenovirus replication in speciﬁc cellular settings where glycolysis
is limiting.
Hepatitis C virus (HCV), a positive strand RNA virus, also
induces glycolysis. Hepatitis C virus infection of Huh7 cells
decreases host cell oxidative phosphorylation and increases
dependence on extracellular glucose (Ripoli et al., 2010). HCV
infectious virus culture systems are derived from a patient with
fulminant hepatitis and these systems require Huh7 cells, a
hepatoma cell line derived from a cellular carcinoma, for
replication. While not an ideal cell line for metabolism studies as
it is derived from a human hepatocellular carcinoma and therefore
has many metabolic changes characteristic of most tumor cell
lines, the HCV replication systems are severely limited. In addition
to an increased requirement for glucose, there is an increase in
lactate production in HCV-infected cells (Ramiere et al., 2014). A
global proteomic screen showed that there is increased expression
of many glycolytic enzymes in HCV infected Huh7 cells, further
indicating that HCV induces glycolysis (Diamond et al., 2010). We
are not aware of studies showing that the increased glycolysis is
necessary for HCV replication, however, based on the studies
described, it is highly likely to be important for some stage of
virus production. As described below, fatty acid synthesis is
required for many stages of HCV replication and assembly and
the induction of glycolysis may be necessary to meet the infected
cell needs for increased fatty acid synthesis. While the viral gene
or genes necessary for HCV induction have not been determined,
the NS5A protein interacts with HK2 to enhance its activity and is
sufﬁcient to induce increased glucose uptake and lactic acid
production (Ramiere et al., 2014). Future work is required to
determine if NS5A is the sole HCV determinant for induction of
glycolysis
While a number of early glycolysis studies focused on trans-
forming retroviruses, recent studies of the non-transforming
lentivirus, HIV, showed that retroviruses directly alter metabolism
as well. Initial proteomic analysis of HIV infected CD4þ T cells
indicated positive changes in glycolysis (Chan et al., 2009). How-
ever, a metabolomics study of HIV infected CD4þ T-cells and
infected macrophages yielded mixed results (Hollenbaugh et al.,
2011). Glucose analogs are taken up to higher levels in the HIV-
infected CD4þ T-cells while the uptake is depressed in the
macrophages. Additionally, metabolites involved in glycolysis were
increased by HIV infection of the CD4þ T-cells while they were
decreased in infected macrophages (Hollenbaugh et al., 2011).
Macrophages generally maintain long-term infection while CD4þ
T-cells most often support more acute lytic infection, which may
account for the differences. This study shows that the activation of
speciﬁc metabolic pathways is dependent on the cell type infected
and further highlights the importance of the cell type tested for
metabolic studies with viruses.
Many other viruses have been shown to induce glycolysis or there
are strong indications that glycolysis is induced by infection. An early
study in 1961 showed that inﬂuenza A infection of chick embryo cell
monolayers increased glucose uptake, glycolysis and lactic acid
production by 3 h post-infection (Klemperer, 1961). A recent targeted
metabolomics study showed that two strains of inﬂuenza A H1N1
induced glucose uptake, glycolytic enzymes and lactic acid production
between 8 and 12 h post-infection (Ritter et al., 2010). As replication
had occurred, they concluded that the increase in glycolysis coincided
with apoptosis of the cells and may be related. However, it is not clear
if inﬂuenza A virus induced apoptosis leads to increased glycolysis or
if the induction of glycolysis delays the course of apoptosis. Other
viruses appear to induce glycolysis without the induction of apoptosis.
Dengue virus, a ﬂavivirus, distantly related to HCV, also induces and
requires glycolysis for efﬁcient replication (Fontaine et al., 2015).
Dengue virus induces glycolysis at relatively early times post-infection
but continues to replicate and produce virus at 48 h post-infection
indicating that apoptosis does not appear to occur early. A virus of
invertebrates has also been shown to induce glycolysis. Metabolism of
shrimp hemocytes was examined following infection with white spot
syndrome virus, a natural pathogen of shrimp. Studies showed that
glucose uptake and lactic acid production were increased during the
replication phase of infection in shrimp (Chen et al., 2011). These
changes occurred prior to virion production and cell death. A
subsequent metabolomics/proteomics study further showed the
induction of aerobic glycolysis at 12 h post-infection of shrimp
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(Su et al., 2014). It is likely that as more viruses are examined, many
will induce and require glycolysis for replication and production of
infectious virus progeny.
While most viruses tested have a requirement for the induction
of glycolysis for viral replication, there are exceptions. Our meta-
bolomics study of HFF cells infected with vaccinia virus, a model
member of the poxviridae, indicated that viral infection does not
induce glycolytic intermediates (Fontaine et al., 2014). Interest-
ingly, there was an increase in intracellular sorbitol and fructose.
When glucose is in excess of the cellular needs, it can be
metabolized to fructose through sorbitol. The metabolomic data
led to the interesting hypothesis that glucose is not utilized by
vaccinia virus-infected cells. In accordance with this hypothesis,
when glucose was removed from the media, vaccinia virus
replicated and produced virions at near wild type levels. While
many viruses induce glycolysis, induction and utilization of glyco-
lysis for viral replication is clearly not universal.
As described above, early studies showed that HSV-1 requires
glucose in the media (Lewis and Scott, 1962) and that the
hexokinase 2 inhibitor, 2-DG, inhibits the production of infectious
virus (Courtney et al., 1973). However, a recent metabolomics
study examined the global metabolic changes induced by two
strains of HSV-1 in multiple cell types and found a very different
metabolic pattern from that of HCMV infected cells (Vastag et al.,
2011). While glycolysis is induced by HCMV in multiple cell types,
HSV-1 does not induce glucose uptake or lactic acid production
and the alteration of glycolytic metabolites has a very different
pattern as compared to HCMV. During infection with HSV-1,
glucose-carbon is not utilized for the TCA cycle to the same extent
as HCMV, but is shunted toward nucleotide synthesis. This study
concluded that HSV-1 does not induce aerobic glycolysis (Vastag
et al., 2011). HCMV has a relatively long replication cycle with
maximal virion production at 96 h post-infection while HSV-1
begins to produce virus within 6 h and has maximal virion
production by 24 h post-infection. Thus, two herpesviruses with
different replication kinetics have very different metabolic needs
and therefore have divergent effects on glycolysis. In contrast to
the metabolomic ﬁndings, a subsequent study of HSV-1 infection
of a different strain of HSV-1 in Vero green monkey kidney cells
found that HSV-1 infection induces glucose uptake and lactic acid
production dependent on phosphofructokinase (Abrantes et al.,
2012). Additional studies found that HSV-1 is inhibited by the
glycolytic inhibitor 2-DG (Courtney et al., 1973; McArdle et al.,
2011). Taken together, these studies show that HSV-1 appears to
require glycolysis for replication but it may not induce this path-
way similarly to HCMV. The requirement for the glycolytic path-
way during HSV-1 infection may lie in the induction of nucleotide
synthesis by HSV-1 that is increased by HSV-1 infection (Vastag
et al., 2011).
Unexpectedly, latent viral infections can also induce glycolysis.
During latent herpesvirus infection there is little or no production of
virions and limited viral gene expression and therefore less obvious
need for rapid metabolic changes. Kaposi's sarcoma-associated her-
pesvirus (KSHV) is the etiologic agent of Kaposi's sarcoma, an
endothelial based tumor. Upon infection of endothelial cells, KSHV
establishes a predominantly latent infection. A metabolomics study of
endothelial cells latently infected with KSHV found that glycolytic
metabolites are induced during latency (Delgado et al., 2012). KSHV
induces the uptake of glucose at least in part through induction of
glucose transporter3 (Delgado et al., 2010). Hexokinase 2, the ﬁrst
rate-limiting enzyme of glycolysis is upregulated during latent infec-
tion by KSHV and there are also increases in the production of lactic
acid leading to increased acidiﬁcation of the media following infec-
tion. Oxygen utilization is decreased in latently infected endothelial
cells indicating that oxidative phosphorylation is diminished. The
induction of glycolysis is essential for the survival of latently infected
cells as inhibition of this pathway led to death of latently infected cells
due to apoptosis (Delgado et al., 2010). Therefore, the switch to
glycolysis induced by viruses is not solely required for nucleic acid
replication or virion assembly and egress but may play a role in cell
survival as well. KSHV is also the etiologic agent of primary effusion
lymphomas (PEL), a pleural cavity lymphoma. The level of glycolysis is
very high in PEL cells as compared to primary B-cells (Bhatt et al.,
2012). PEL cells are isolated from a human tumor so it is formally
difﬁcult to separate out if glycolysis is altered due to viral infection or
to tumor formation in general. However, the PEL cell data is consistent
with viral induction of glycolysis.
Recently, it was shown that the KSHV encoded microRNAs are
sufﬁcient to induce aerobic glycolysis (Yogev et al., 2014). KSHV
encodes over 17 distinct microRNA species from 12 loci. The
microRNAs are encoded in the major latent locus and are expressed
during latent infection. Ten of the 12 KSHV miRNA loci are
intergenic. When these 10 intergenic viral microRNAs were over-
expressed in endothelial cells there was an increase in lactic acid
production and a decrease in oxygen utilization. The microRNA
cluster also induces hypoxia induced factor 1 and upregulates the
expression of glucose transporter 1. These effects appear to be due
to the microRNA repression of two metabolic regulatory genes,
EGLN2 and HSPA9 (Yogev et al., 2014). It remains to be seen if the
KSHV miRNAs are necessary for the induction of glycolysis in the
context of KSHV infection or if other latently expressed genes are
also able to induce glycolysis. Regardless, these results show that
KSHV has evolved functions to induce glycolysis and the induction
of glycolysis is not a simple cellular response to infection.
Epstein-Barr virus (EBV) is the causative agent of infectious
mononucleosis and also causes a number of malignancies includ-
ing Burkitt's lymphoma and nasopharyngeal carcinoma (NPC). EBV
infected NPC cell lines have high levels of glycolysis, an effect
recapitulated by the expression of a known EBV oncogene
expressed during many forms of latency, latent membrane protein
1 (LMP-1) (Xiao et al., 2014). LMP-1 induces the expression of HK2,
leading to the induction of glycolysis. Knockdown of HK2 in the
LMP expressing NPC cells leads to an increase in cell death,
indicating that the induction of glycolysis is necessary for survival
of the cells. The importance of glycolysis during latent infection is
highlighted by the fact that both KSHV and EBV induce glycolysis
during latent infection. In both cases, latently expressed genes are
sufﬁcient to induce the effect indicating that latent viral infection
directly induces glycolysis. Both KSHV and EBV are oncogenic
viruses in speciﬁc environments and both viruses induce meta-
bolic pathways induced in most cancer cells while keeping the
infected cell alive, leading to speculation as to the role of virus
induced metabolism in viral oncogenesis.
While many viruses induce and require glycolysis, its exact role
in viral replication and during latent infections is not entirely clear.
If glucose uptake and utilization is increased, ATP can be produced
more rapidly through aerobic glycolysis. Therefore, viruses may
have evolved to induce glycolysis for a rapid source of ATP for
replication. In the cancer ﬁeld, it has been postulated that ATP is
not generally limiting and that aerobic glycolysis increases bio-
mass for a growing cell (DeBerardinis et al., 2008). Viruses may
require this biomass for replication or for the maintenance of
latently infected cells. Increased glucose uptake may also be
required to feed other metabolic pathways during viral infection.
Importantly, fatty acid synthesis is required for the replication of
many viruses and increased glucose may feed this pathway in
many virus-infected cells. The need for glycolysis for different
viruses ranges widely as exempliﬁed by the comparison of HSV-1
and CMV in the same cell type (Vastag et al., 2011). Determining
which aspects of glycolysis are necessary for each virus studied
will be important for understanding the different requirements for
the induction of glycolysis by distinct viruses.
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Fatty acid synthesis
Fatty acid synthesis supports the creation of lipid material in
the cell and is important for increased membrane production as
well as other cellular needs. The core of fatty acid synthesis is the
production of palmitate from acetyl-CoA and malonyl-CoA in a
reaction that requires NADPH and is catalyzed by fatty acid
synthase (FASN). In mammalian cells, the carbon substrates for
fatty acid synthesis are generally derived from citrate, an inter-
mediate of the TCA cycle. Once synthesized, palmitate can be
further metabolized into a number of long chain fatty acids that
can then be used in lipid production for membrane biosynthesis
and lipid droplet formation. Lipid droplets are storage organelles
for lipids, triacylglycerides and sterol esters and are also beneﬁcial
as energy storage for cells. Lipid droplet formation can be
indicative of increased fatty acid synthesis and prepares the cell
for rapid membrane generation and maintains an energy cache.
Fatty acids can also be broken down by beta-oxidation to produce
energy. Importantly, many viruses induce and require fatty acid
synthesis at some stage of their lifecycle.
Carbon ﬂux studies of HCMV infected cells indicated that
during lytic replication HCMV induces the ﬂux of glucose-
derived carbon into fatty acid synthesis in primary HFF cells
(Munger et al., 2008). There is a marked increase in ﬂux of carbon
into citrate and into malonyl-CoA ﬂux and therefore glucose is
feeding fatty acid synthesis as well as the TCA cycle in HCMV
infected cells as described above. Radiolabeled glucose carbon is
also found in lipid material at higher levels in HCMV infected cells
as compared to mock directly demonstrating that HCMV induces
fatty acid synthesis (Munger et al., 2008). Fatty acid synthesis is
required for HCMV production inasmuch as inhibitors of enzymes
critical for fatty acid synthesis, both acetyl-CoA carboxylase (ACC)
and FASN, lead to a signiﬁcant decrease in the release of infectious
HCMV particles (Munger et al., 2008). FASN and ACC inhibitors did
not have any signiﬁcant effect on early or late viral gene expres-
sion and therefore fatty acid synthesis must be necessary for a
post-gene expression step (Munger et al., 2008). Therefore, the
inhibition of HCMV by fatty acid synthesis inhibitors was not
simply damaging the cell but was required for the production of
infectious virus.
The mechanism of HCMV induced fatty acid synthesis is not
entirely clear. However, infection of ﬁbroblast cells induces
enzymes involved in fatty acid synthesis, in particular ACC1
(Spencer et al., 2011). Early viral gene expression is required for
the induction of ACC1. Activation of the sterol regulatory element
binding protein 1 (SREBP-1) via protein cleavage is necessary for
the induction of ACC and other FAS enzymes by HCMV (Yu et al.,
2012). Inhibition of SREBP-1 inhibits HCMV induced fatty acid
synthesis and the production of infectious virions but does not
inhibit production of viral early or late proteins. This conﬁrms that
the block in virion production is not due to a lack of viral gene
expression. It was subsequently shown that SREBP-1 is activated
by PKR-like endoplasmic reticulum kinase (PERK) (Yu et al., 2013).
PERK is activated by cellular stress raising the possibility that
cellular stress due to infection is part of the induction of fatty acid
synthesis in HCMV infected cells and that the virus has evolved to
utilize this response for production of infectious virus. The induc-
tion of glycolysis by HCMV induces relocalization of carbohydrate-
response binding element protein (ChREBP) (Yu et al., 2014). In
turn, ChREBP activates fatty acid synthesis. Therefore, HCMV
induction of glycolysis may also play a role in HCMV induction
of fatty acid synthesis. Glut4 and ChREBP can also be controlled by
viperin, an interferon inducible protein and restriction factor of
HIV. Viperin relocalization to the mitochondria is required for
HCMV induced fatty acid synthesis and knockdown of viperin
leads to an increase in non-enveloped virus particles within HCMV
infected cells (Seo and Cresswell, 2013). Therefore, HCMV-induced
fatty acid synthesis may be required for virion envelopment
within the cell. Alternatively, it has also been postulated that
HCMV induction of fatty acid synthesis may be necessary for the
massive increase in the size of the cell nucleus in HCMV infected
cells (Yu et al., 2011a). Future work will tease out these
possibilities.
A screen utilizing siRNAs to knock down speciﬁc cellular
enzymes involved in metabolism, identiﬁed a number of fatty
acid synthesis enzymes that were important for the production of
infectious HCMV (Koyuncu et al., 2013). Knockdown of a number
of enzymes involved in the production of very long chain fatty
acids (VLCFA) led to signiﬁcant inhibition of HCMV. HCMV infec-
tion leads to increased expression of many enzymes involved in
VLCFA synthesis, including acyl-CoA synthetases and the elon-
gases, enzymes that elongate long chain fatty acids. Labeled very
long chain fatty acids were found at high levels in the virion
envelope (Koyuncu et al., 2013). Drug inhibition of the enzymes
involved in VLCFA production and induced by HCMV did not
inhibit early or late HCMV gene expression but led to a 15-fold
decrease in virion production. However, the VLCFA synthesis
inhibitors led to an approximately 350-fold increase in the particle
to pfu ratio, demonstrating that the VLCFAs in the virion envelope
are required for the virion to become infectious (Koyuncu et al.,
2013). It is unknown if the VLCFAs are necessary for binding to
subsequent host cells or for virion envelope integrity. It also
remains to be determined if fatty acid synthesis is solely required
for the creation of VLCFA or if it is necessary for additional facets of
HCMV virion production.
Other herpesviruses also appear to require fatty acid synthesis
during lytic replication. A FASN inhibitor, cerulinin, blocks the
production of varicella zoster virus (VZV) without affecting protein
synthesis (Namazue et al., 1989). In VZV-infected cells fatty acid
synthesis may be necessary for the increased glycoprotein expres-
sion as labeled palmitate added to VZV infected cells could be
found in virion glycoproteins (Namazue et al., 1989). EBV also
induces FASN in human epithelial tongue cells from a patient with
oral hairy leukoplakia (Li et al., 2004). An EBV immediate early
protein, BRLF1 was shown to induce FASN (Li et al., 2004). The
reactivation of EBV lytic replication is blocked by FASN inhibitors,
apparently in a BRLF dependent fashion at early times after the
induction. However, not all herpesviruses induce overt fatty acid
synthesis. The metabolomics study of HSV-1 found that infection
does not induce metabolites involved in fatty acid synthesis and
the production of infectious HSV-1 was unaffected by FASN
inhibitors (Vastag et al., 2011). Therefore, while common, induc-
tion of fatty acid synthesis is not universal among viruses with
differences even within the same family.
RNA viruses that replicate in the cytoplasm alter lipids in the
cytoplasm to create a beneﬁcial environment for replication
(Chukkapalli et al., 2012; Heaton and Randall, 2011). Virtually all
aspects of the HCV lifecycle, from entry to egress and even
extracellular virion particles are lipid associated (Schaefer and
Chung, 2013). HCV requires low-density lipoprotein receptor as a
co-factor for entry. HCV replication occurs on lipid raft-like
domains, often referred to as membranous webs, and HCV
assembly appears to occur on lipid droplets. To create a replication
compartment and increase assembly sites, HCV induces and
requires fatty acid synthesis and lipid droplets. The role of fatty
acid synthesis in these steps of the HCV lifecycle has been
reviewed extensively elsewhere and will not be described at
length here (Herker and Ott, 2011; Schaefer and Chung, 2013;
Syed et al., 2010; Targett-Adams et al., 2010). HCV was originally
shown to induce enzymes involved in fatty acid synthesis in vivo
in chimpanzees (Su et al., 2002). Subsequent studies showed that
fatty acid synthesis is necessary for HCV replication (Kapadia and
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Chisari, 2005). HCV induces activation of the SREBPs and also
induces FASN to increase fatty acid synthesis (Waris et al., 2007;
Yang et al., 2008). Lipidomic and metabolomics studies of HCV-
infected Huh7 cells show that HCV induces speciﬁc lipid moieties
including several phosphatidylcholine and phosphatidyethanola-
mine species as well as cholesterol and sphingolipids (Diamond
et al., 2010; Roe et al., 2011). Further studies will likely determine
the need for these speciﬁc lipids in HCV replication and assembly.
HCV assembly is associated with lipid droplets (Herker and Ott,
2011; McLauchlan, 2009). The HCV core protein co-localizes with
lipid droplets in cell culture and in chimpanzee liver bioposies
(Barba et al., 1997). When the HCV core protein was expressed in
some strains of transgenic mice it led to the induction of lipid
droplets and ultimately caused steatosis, also known as fatty liver
disease (Moriya et al., 1997). Importantly, steatosis occurs in more
than half of HCV patients. Therefore, in addition to being required
for replication and assembly, the induction of fatty acid synthesis
by HCV appears to directly lead to a major disease induced by
the virus.
Dengue virus also rearranges speciﬁc membrane structures for
replication and requires fatty acid synthesis for replication. A
directed siRNA screen showed that FASN and ACC1 were required
for efﬁcient dengue virus replication (Heaton et al., 2010). Inhibi-
tion of fatty acid synthesis by drugs that inhibit FASN also leads to
signiﬁcant decreases in dengue virus replication. Dengue virus
does not appear to increase the expression level of FASN but rather
causes a relocalization of FASN to the novel membrane structures
induced by the virus (Heaton et al., 2010). The dengue virus
nonstructural protein, NS3 drives relocalization of FASN (Heaton
et al., 2010) and this relocalization appears to involve Rab18
binding to NS3 (Tang et al., 2014). Dengue virus infection increases
overall fatty acid synthesis in host cells as determined by increased
uptake of radiolabelled acetate with the highest amount of label
found in the subcellular fractions that contained dengue virus RNA
(Heaton et al., 2010). The increase in fatty acid synthesis may lead
to the increased lipid droplet formation found in dengue virus
infected baby hamster kidney cells (Samsa et al., 2009). Inhibitors
of FASN also decrease the recovery of infectious dengue virus in
mosquito cells without apparent effects on cell viability (Perera
et al., 2012; Samsa et al., 2009). Therefore, in both human cells and
in its arthropod host, dengue virus requires fatty acid synthesis for
production of infectious virus. Lipidomics of dengue virus infected
mosquito cells showed that, similarly to HCV, sphingolipids and a
number of phospholipids were upregulated by dengue virus
infection (Perera et al., 2012). Palmitic acid, among other primary
fatty acids, was also elevated by dengue virus infection. An
inhibitor of FASN prevented the increase of these fatty acids in
dengue virus infected cells, suggesting that the induction of fatty
acids is most likely due to a requirement for biosynthesis, not
breakdown. However, there is evidence that dengue virus induced
autophagy leads to a break down of fatty acids by beta-oxidation
to increase available ATP (Heaton and Randall, 2010). Future
studies will be necessary to determine under which conditions
dengue virus leads to induction and accumulation of fatty acids
and when it leads to breakdown for energy.
It has been known for some time that Poliovirus, a non-
enveloped virus, increases the production of phosphatidylcholine
(Mosser et al., 1972) and it was subsequently shown that Poliovirus
requires fatty acid synthesis for replication (Guinea and Carrasco,
1990). Recently, it was shown that Poliovirus induces not only
fatty acid synthesis but also cellular uptake of extracellular long
chain fatty acids (Nchoutmboube et al., 2013). The rapid uptake of
extracellular fatty acids does not lead to lipid droplets as expected,
but instead these fatty acids are incorporated into phosphatidyl-
choline. Knockdown of a single acyl-CoA synthetase, Acsl3, a
protein involved in fatty acid uptake, led to inhibition of poliovirus
replication (Nchoutmboube et al., 2013). A single poliovirus
protein, 2A, was necessary but not sufﬁcient for induced fatty acid
uptake. Other picornaviruses also induce uptake of extracellular
fatty acids as well, thus, it may be fruitful to determine the need
for uptake of extracellular fatty acids for other virus families.
Poxviruses are DNA viruses that replicate in the cytoplasm, and
therefore, like RNA viruses might require alteration of cellular
membranes. The production of vaccinia virus is inhibited by a
FASN inhibitor (Punjabi and Traktman, 2005). It was subsequently
shown that inhibition of FASN could be overcome by the addition
of palmitate, a metabolite downstream of FASN in the fatty acid
synthesis pathway (Greseth and Traktman, 2014). However, inhi-
bition of phospholipid synthesis did not inhibit virus production.
Vaccinia virus appears to require fatty acid synthesis for beta-
oxidation of palmitate to increase energy in the cell by feeding the
TCA cycle (Greseth and Traktman, 2014). As described above,
vaccinia virus does not induce or require glycolysis and therefore
may need alternative pathways to generate metabolic intermedi-
ates in the TCA cycle (Fontaine et al., 2014). Further studies are
necessary to understand why vaccinia virus requires fatty acid
synthesis for energy via subsequent beta-oxidation rather than
inducing glycolysis as many other viruses do.
An RNA virus that replicates in the nucleus also requires fatty
acid synthesis. Inﬂuenza is in one of the few RNA virus families,
Orthomyxoviridae, that replicates in the cytoplasm. A metabolo-
mics study showed increases in fatty acid synthesis metabolites
and cholesterol metabolism following inﬂuenza A infection of two
different transformed cell lines (Lin et al., 2010). It was also shown
that inﬂuenza A virus production is decreased by inhibitors of fatty
acid synthesis (Munger et al., 2008). Therefore, regardless of the
replication compartment in the cell, many viruses require fatty
acid synthesis for replication or the production of infectious virus
particles.
Latent herpesvirus infection can also induce fatty acid synth-
esis. As described above, infection of cultured endothelial cells
with KSHV leads to a predominantly latent infection. In our
metabolomics study of latently infected endothelial cells, most of
the long chain fatty acids detected are upregulated by infection at
48 h post-infection and this increase is maintained at 96 h post-
infection (Delgado et al., 2012). There is also a signiﬁcant increase
in the staining of lipid droplets in the latently infected cells.
Inhibition of FASN or ACC1 leads to death by apoptosis for the
majority of the latently infected cells (Delgado et al., 2012).
Therefore, during latent infection, where there is limited viral
replication, fatty acid synthesis is required for cell survival. Fatty
acid synthesis is also induced in the primary effusion lymphoma
cell lines and this was speciﬁc to PELs versus other non-hodgekin
lymphomas indicating this effect may be virus related as well
(Bhatt et al., 2012). Lipid droplets are also induced in Burkitt's
lymphomas that contain latent EBV suggesting that latent EBV
infection may also induce fatty acid synthesis. Therefore, latent
infection by herpesviruses appears to induce and, at least in the
case of KSHV, require fatty acid synthesis for infected cell survival.
Upon latent infection of endothelial cells, KSHV does not induce
rapid cell growth; therefore, fatty acid synthesis is not likely to be
necessary for rapid membrane production. It is possible that
induced fatty acid synthesis is necessary for energetic needs
during latency. Further studies are needed to determine the role
of induced fatty acid synthesis for cell survival during latency.
Fatty acid synthesis is induced and required for replication and
virus production of most but not all viruses examined. For all RNA
viruses where metabolism has been studied, fatty acid synthesis is
induced and required for replication. Most RNA viruses replicate in
the cytoplasm and require remodeling of membrane compart-
ments for replication. Induction of fatty acid synthesis is likely to
aid in membrane remodeling to create speciﬁc niches for viral RNA
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replication. Vaccinia virus, a DNA virus that replicates in the
cytoplasm, also requires induction of FAS, but this induction may
be required for energy through beta-oxidation (Greseth and
Traktman, 2014). With the exception of HSV-1, both RNA and
DNA viruses that replicate in the nucleus also require fatty acid
synthesis. However, it is less clear what the exact need for newly
synthesized lipids is during virus replication. Both HCMV and VZV
appear to utilize induced fatty acid synthesis to create species
present in their virion envelope or in the virion glycoproteins,
indicating that induction of fatty acid synthesis can provide extra
virion components for rapid replication of viruses (Koyuncu et al.,
2013; Namazue et al., 1989). Many normal cells can survive for
some time when fatty acid synthesis is blocked. Therefore, the
inhibition of fatty acid synthesis could provide novel therapeutic
targets for blocking viral infection.
Glutaminolysis
While glutamine is a non-essential amino acid, extracellular
glutamine is often imported for multiple cellular metabolic path-
ways. Glutamine can be utilized for glutathione production,
ammonia production, and purine synthesis through nitrogen
donation among other uses. Importantly, glutamine can be utilized
in glutaminolysis. In glutaminolysis, glutamine is converted to
glutamate and then to alpha-ketoglutarate. Alpha-ketoglutarate
can enter the mitochondria where it can be utilized as an
intermediate of the TCA cycle. Cancer cells often become gluta-
mine addicted. In many cancer cells, glucose carbon is shunted
away from the TCA cycle both into lactic acid production as well as
fatty acid synthesis. Glutamine is then required as an anaplerotic
substrate to replenish the TCA cycle. A number of viruses have also
been shown to require glutamine for replication.
In the 1950s, it was shown that glutamine, as well as glucose,
was necessary for maximal poliovirus replication in Hela cells
(Darnell and Eagle, 1958; Eagle and Habel, 1956). Supplementing
glutamine to the media actually restored more virus production
than adding back glucose. Glutamic acid produced the same effect,
the ﬁrst hint that glutaminolysis might be necessary for viral
replication (Darnell and Eagle, 1958). In 2008, it was ﬁrst shown
that HCMV infection led to increased uptake of glutamine (Munger
et al., 2008). Interestingly, in the absence of glucose in the media,
HCMV-infected HFF cells live longer than uninfected cells
(Chambers et al., 2010). This ﬁnding led to the hypothesis that in
HCMV-infected cells, glutamine could supplant glucose as a
primary energy source. As predicted, HCMV induces the consump-
tion of glutamine and the production of ammonia, and the speciﬁc
activity of multiple enzymes involved in glutaminolysis is
increased (Chambers et al., 2010). In the absence of glutamine in
the media, HCMV infected cells have decreased levels of ATP and
there is a signiﬁcant loss of virus production (Chambers et al.,
2010). Both ATP levels and virus production can be rescued by TCA
cycle intermediates, further demonstrating that glutamine is
needed as an anaplerotic substrate for the TCA cycle (Chambers
et al., 2010). As described above, HCMV induces glucose uptake
and glycolysis but the glucose carbon is used for fatty acid
synthesis and nucleotide synthesis and, therefore, glutamine is
necessary to provide metabolites for the TCA cycle, similarly to
many cancer cells.
Vaccinia virus is one of the few viruses that does not induce or
require glycolysis for replication in cultured cells. A metabolomics
study of primary HFF cells infected with vaccinia showed that
there is no increase in glycolytic metabolites but there is an
increase in intracellular glutamine and glutamate (Fontaine et al.,
2014). Removal of glutamine, but not glucose, from the media led
to a signiﬁcant drop in virus production. In the absence of
glutamine, late genes were expressed at low levels though the
maturation of processed late genes occurred. Electron microscopy
studies showed that in the absence of glutamine, immature and
mature virus particles are produced but at drastically reduced
levels, with only small virus factories in the cytoplasm (Fontaine
et al., 2014). Virus factory levels and the production of infect-
ious virus can be restored by supplementation with alpha-
ketoglutarate as well as other TCA cycle intermediates. Therefore,
as with HCMV, glutamine is required as an anaplerotic substrate
for the TCA cycle. The glutamine dependence of vaccinia virus was
subsequently conﬁrmed in transformed African green monkey
BSC40 cells (Greseth and Traktman, 2014). Vaccinia virus increases
the metabolites in glutaminolysis at very early time points in
human ﬁbrosarcoma cell line, though less so in Hela cells, high-
lighting the cell speciﬁcity of some virus-induced metabolic
changes (Mazzon et al., 2014). In both cell lines, a virus deleted
for the C16 protein, a protein that stabilizes HIF-1, has lower levels
of glutamine metabolites compared to wild type infection indicat-
ing that the induction of glutaminolysis may, at least in part, be
due to this viral protein.
Why vaccinia virus has evolved to rely solely on glutamine
uptake, while both poliovirus and HCMV require induction of both
glycolysis and glutaminolysis is unknown. Perhaps that answer lies
in the differential utilization of fatty acid synthesis, vaccinia relies
on beta-oxidation for energy while HCMV relies on longer chain
fatty acids (Greseth and Traktman, 2014; Koyuncu et al., 2013).
Further work is required to fully understand how glutamine is
utilized in the vaccinia virus infected cell. In contrast, dengue virus
relies on glycolysis for replication with only a small drop in titer in
the absence of glutamine (Fontaine et al., 2015). Therefore, viruses
have evolved to utilize different carbon sources and future studies
of carbon utilization for each virus species are warranted.
Viruses appear to induce glutaminolysis when glucose carbon
is shunted away from the TCA cycle. It remains to be seen if the
requirement for the TCA cycle lies solely in energy production or if
TCA cycle intermediates are needed for virus replication. During
latent KSHV infection of endothelial cells, carbon from glucose is
utilized for aerobic glycolysis and the production of lactate while
fatty acid synthesis is also induced (Delgado et al., 2010; Delgado
et al., 2012). Our previously described metabolomics study showed
that the latently infected cells have higher levels of glutamine as
compared to their mock counterparts (Delgado et al., 2012). In
preliminary studies we found that endothelial cells latently
infected with KSHV induce glutamine uptake and that glutamino-
lysis is required for the survival of latently infected cells (Sanchez
et al., 2015). These data support the hypothesis that glutaminolysis
is required for cellular energy during infection.
Looking forward
In the last decade, great strides have been made in the under-
standing of the metabolic pathways that are altered by viruses for
genome replication, virion production and for enhanced survival of
infected cells. While there are common metabolic changes induced
by most viruses studied, there are also unique metabolic perturba-
tions for each virus species necessitating the study of each virus
species individually. There is also likely to be additional metabolic
pathways that are commonly affected by many viruses. For example,
a number of the large-scale metabolomics studies have identiﬁed
increases in amino acid metabolism and nucleotide synthesis.
The alteration of metabolites in the pentose phosphate pathway
(PPP) has been noted in a number of metabolomic studies (Delgado
et al., 2012; Hollenbaugh et al., 2011; Vastag et al., 2011). The
PPP metabolizes glucose to ribulose-5-phosphate, an important
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substrate for nucleotide synthesis (Fig. 1). Given the need for rapid
viral genome replication, the PPP may provide a source of free
nucleotide pools as was shown for adenovirus infection (Thai et al.,
2014). Additionally, the PPP generates net NADPH. NADPH is an
essential substrate for fatty acid synthesis. Therefore, virus induc-
tion of one metabolic pathway may require induction of other
pathways to provide all the necessary substrates. As many metabolic
pathways are inter-related, it is not surprising that the activation of
one pathway requires the activation of other pathways. Therefore,
future virus-induced metabolism studies will likely identify novel
inter-related metabolic pathways that will advance our understand-
ing of cellular metabolism in general.
The exact stage in the virus life cycle that each metabolic
pathway is required for is a fertile ground for future studies. The
metabolites or metabolic pathways required for speciﬁc virion
components have been identiﬁed for a couple of viruses thus far
(Koyuncu et al., 2013; Namazue et al., 1989). Recently, HCMV was
shown to induce pyrimidine biosynthesis to increase UDP-sugars
that are utilized for increased synthesis of viral glycoproteins
(DeVito et al., 2014). Herpesviruses encode for multiple glycopro-
teins present in the virus envelope and these glycoproteins are
used for binding to host cells. Inhibition of the pyrimidine
biosynthesis led to a decrease in the glycosylation of a viral
envelope protein, gB (DeVito et al., 2014). The inhibitor of
pyrimidine biosynthesis also led to an increase in the particle to
pfu ratio as would be expected if there are decreased levels of viral
glycoproteins on the virion envelope. These examples show that
viral induction of certain metabolic pathways may beneﬁt the
virus by producing increased levels of speciﬁc virion components.
Many of the metabolic pathways induced by viruses, however, are
likely to be for efﬁcient energy production and substrates less
directly involved in the formation of infectious virions. Delineating
the need for induction of each metabolic pathway for each virus
species will increase our understanding of why viruses have
evolved to target distinct metabolic pathways.
There are surprisingly few studies describing the mechanisms
of virus induced cellular metabolism. The cellular signaling path-
ways necessary for viral induction of metabolic pathways have
been identiﬁed in a few cases. However, a deeper understanding of
these signaling pathways is critical for the goal of therapeutically
targeting viral infections through inhibition the speciﬁc pathologic
metabolic pathways. There are only a couple examples where the
viral gene products necessary for changes in each speciﬁc meta-
bolic pathway have been identiﬁed and these studies have gen-
erally followed the cancer cell metabolism ﬁeld. Future studies to
identify the viral genes driving metabolic changes will advance the
mechanistic studies beyond current levels.
Many similarities between metabolic pathways induced by viral
infection and the pathways induced in cancer have been noted. The
viral metabolism ﬁeld has drawn heavily on what is known in
cancer cell metabolism to identify cellular mechanisms of metabolic
induction. Further identiﬁcation of virus-activated host signaling
pathways that control cellular metabolism will not only lead to a
deeper understanding of the importance of viral induced metabo-
lism but will also facilitate discoveries in cancer cell metabolic
control. Therefore a deeper understanding of virus induced meta-
bolic pathways will have the potential to identify novel antivirals as
well as new ways to target cancer metabolism.
Fig. 1. Virus infection alters host cell metabolism. Major metabolic pathways altered by virus infection are highlighted, glycolysis (green), fatty acid synthesis, FAS (orange),
glutaminolysis (purple), pentose phosphate pathway, PPP (dark blue). Glucose enters the cell and is metabolized to glucose-6-phosphate (G-6-P) which can be shunted to the
PPP to support nucleotide synthesis, or to pyruvate. Pyruvate can be converted to lactate via glycolysis, which is secreted from the cell, or acetyl-CoA (ACoA), which enters
the TCA cycle. Citrate can be shunted out of the mitochondria to enter FAS. Glutamine enters the cell and is deaminated twice to form αKG and ammonia (NH3). αKG can then
enter the TCA cycle. Major enzymes of carbon metabolism are in turquoise and discussed in main text.
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